FHL1 is a multifunctional protein involved in cellular processes such as signal transduction, transcriptional regulation, and cytoskeletal organization. The activators within this chemical class interact with FHL1, modulating its functions through various molecular mechanisms. Understanding the specific binding sites and conformational changes induced by these activators can provide valuable insights into the regulatory pathways in which FHL1 participates. Four and a half LIM domains protein 1 (FHL1) activators are a diverse group of compounds that indirectly influence the activity of FHL1 by affecting various intracellular signaling pathways. The MAPK/ERK pathway, stimulated by compounds such as Epidermal Growth Factor and Brain-Derived Neurotrophic Factor, leads to the activation of downstream transcription factors that can enhance the expression of FHL1. The PI3K/AKT pathway, activated by Platelet-Derived Growth Factor and Insulin, upregulates AP-1, a transcription factor that promotes FHL1 expression. Other growth factors like Vascular Endothelial Growth Factor and Transforming Growth Factor Beta activate the JAK/STAT pathway and SMAD proteins respectively, both of which enhance FHL1 expression.
The activation of FHL1 by these compounds is critical for its role in cellular processes, and researchers employ a variety of methods to elucidate the interaction between FHL1 and its activators. Structural biology techniques, such as X-ray crystallography or nuclear magnetic resonance (NMR) spectroscopy, can be employed to determine the three-dimensional structures of FHL1 in complex with its activators, revealing the precise binding sites and molecular interactions. Additionally, biochemical assays, such as enzyme kinetics studies, can help characterize the impact of these activators on FHL1's enzymatic or signaling activities. Overall, the investigation into FHL1 activators not only sheds light on the molecular mechanisms governing FHL1 function but also provides a foundation for understanding the broader cellular processes in which FHL1 is implicated.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Forskolin can activate adenylyl cyclase, leading to an increase in cAMP levels, which can enhance PKA activity, leading to the activation of CREB, a transcription factor that promotes FHL1 expression. | ||||||
Insulin | 11061-68-0 | sc-29062 sc-29062A sc-29062B | 100 mg 1 g 10 g | $156.00 $1248.00 $12508.00 | 82 | |
Insulin engages the IRS/PI3K/AKT pathway, which can upregulate AP-1, a transcription factor that promotes FHL1 expression. | ||||||
Luteolin | 491-70-3 | sc-203119 sc-203119A sc-203119B sc-203119C sc-203119D | 5 mg 50 mg 500 mg 5 g 500 g | $27.00 $51.00 $101.00 $153.00 $1925.00 | 40 | |
Luteolin can inhibit PI3K/AKT signaling, reducing the inhibitory effects of this pathway on FHL1 expression. | ||||||
Resveratrol | 501-36-0 | sc-200808 sc-200808A sc-200808B | 100 mg 500 mg 5 g | $80.00 $220.00 $460.00 | 64 | |
Resveratrol can activate the SIRT1 pathway, which has been linked to the upregulation of FHL1. | ||||||
Curcumin | 458-37-7 | sc-200509 sc-200509A sc-200509B sc-200509C sc-200509D sc-200509F sc-200509E | 1 g 5 g 25 g 100 g 250 g 1 kg 2.5 kg | $37.00 $69.00 $109.00 $218.00 $239.00 $879.00 $1968.00 | 47 | |
Curcumin can activate Nrf2, a transcription factor that can enhance FHL1 expression. | ||||||
Quercetin | 117-39-5 | sc-206089 sc-206089A sc-206089E sc-206089C sc-206089D sc-206089B | 100 mg 500 mg 100 g 250 g 1 kg 25 g | $11.00 $17.00 $110.00 $250.00 $936.00 $50.00 | 33 | |
Quercetin can inhibit PI3K/AKT signaling, reducing the inhibitory effects of this pathway on FHL1 expression. | ||||||
Retinoic Acid, all trans | 302-79-4 | sc-200898 sc-200898A sc-200898B sc-200898C | 500 mg 5 g 10 g 100 g | $66.00 $325.00 $587.00 $1018.00 | 28 | |
Retinoic acid manages cellular proliferation and differentiation through the activation of retinoic acid receptors (RARs), which can enhance FHL1 expression. | ||||||
Dexamethasone | 50-02-2 | sc-29059 sc-29059B sc-29059A | 100 mg 1 g 5 g | $91.00 $139.00 $374.00 | 36 | |
Dexamethasone, a glucocorticoid, can activate the glucocorticoid receptor (GR), enhancing FHL1 expression indirectly. | ||||||
Cholecalciferol | 67-97-0 | sc-205630 sc-205630A sc-205630B | 1 g 5 g 10 g | $71.00 $163.00 $296.00 | 2 | |
Vitamin D3 activates the Vitamin D receptor (VDR), leading to FHL1 gene expression. | ||||||